Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 206-216

  Hevir, N ^a   Trost N ^a   Debeljak, N ^a   Lanisnik Rizner T ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

17 Hydroxysteroid dehydrogenases (17 HSDs); Aldo keto reductases (AKRs); Aromatase; Catechol O methyl transferase (COMT); Sulfatase; Sulfotransferases; UDP Glucuronosyl transferase (UGT)

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; ALDEHYDE REDUCTASE; ALDO KETO REDUCTASE FAMILY 1 MEMBER C3; AROMATASE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN SULFOTRANSFERASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE P1; HYDROXYSTEROID SULFOTRANSFERASE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; STEROID DELTA ISOMERASE; STERYL SULFATASE; SULFATASE; SULFOTRANSFERASE; SULFOTRANSFERASE FAMILY CYTOSOLIC 2B MEMBER 1; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 1; TESTOSTERONE 17BETA DEHYDROGENASE 10; TESTOSTERONE 17BETA DEHYDROGENASE 2; TESTOSTERONE 17BETA DEHYDROGENASE 7; UNCLASSIFIED DRUG;

AROMATIZATION; BREAST CANCER; CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYMES; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 79955721502     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.12.013     Document Type: Conference Paper

References (53)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN, Int. J. Cancer (2008).
2. M. Clemons, P. Goss, Estrogen and the risk of breast cancer, N. Engl. J. Med. 344 (2001) 276-285. (Pubitemid 32108534)
3. F.F. Parl, K.M. Egan, C. Li, P.S. Crooke, Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction, Cancer Inform. 7 (2009) 109-121.
4. A.H. Eliassen, S.A. Missmer, S.S. Tworoger, D. Spiegelman, R.L. Barbieri, M. Dowsett, S.E. Hankinson, Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women, J. Natl. Cancer Inst. 98 (2006) 1406-1415.
5. A. Subramanian, M. Salhab, K. Mokbel, Oestrogen producing enzymes and mammary carcinogenesis: a review, Breast Cancer Res. Treat. 111 (2008) 191-202.
6. B.E. Henderson, H.S. Feigelson, Hormonal carcinogenesis, Carcinogenesis 21 (2000) 427-433. (Pubitemid 30137927)
7. J.L. Bolton, G.R. Thatcher, Potential mechanisms of estrogen quinone carcinogenesis, Chem. Res. Toxicol. 21 (2008) 93-101. (Pubitemid 351219711)
8. B.T. Zhu, A.H. Conney, Functional role of estrogen metabolism in target cells: review and perspectives, Carcinogenesis 19 (1998) 1-27. (Pubitemid 28376821)
9. T. Lanišnik Rižner, Estrogen metabolism and action in endometriosis, Mol. Cell. Endocrinol. 307 (2009) 8-18.
10. H. Sasano, T. Suzuki, T. Nakata, T. Moriya, New development in intracrinology of breast carcinoma, Breast Cancer 13 (2006) 129-136.
11. T. Šmuc, T. Lanišnik Rižner, Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer, Mol. Cell. Endocrinol. 301 (1-2) (2009) 74-82.
12. K. Ito, H. Utsunomiya, N. Yaegashi, H. Sasano, Biological roles of estrogen and progesterone in human endometrial carcinoma - new developments in potential endocrine therapy for endometrial cancer, Endocr. J. 54 (2007) 667-679. (Pubitemid 351377743)
13. J.D. Graham, C.L. Clarke, Physiological action of progesterone in target tissues, Endocr. Rev. 18 (1997) 502-519.
14. J.P. Wiebe, D. Muzia, J. Hu, D. Szwajcer, S.A. Hill, J.L. Seachrist, The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion, Cancer Res. 60 (2000) 936-943. (Pubitemid 30129529)
15. T.M. Penning, Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action, Hum. Reprod. Update 9 (2003) 193-205.
16. C. Prehn, G. Moller, J. Adamski, Recent advances in 17beta-hydroxysteroid dehydrogenases, J. Steroid Biochem. Mol. Biol. 114 (2009) 72-77.
17. R. Raftogianis, C. Creveling, R. Weinshilboum, J. Weisz, Chapter 6: estrogen metabolism by conjugation, J. Natl. Cancer Inst. Monogr. (2000) 113-124.
18. T.M. Penning, D.R. Bauman, Y. Jin, T. Lanišnik Rižner, Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor, Mol. Cell. Endocrinol. 265-266 (2007) 77-82. (Pubitemid 46273954)
19. J.D. Yager, N.E. Davidson, Estrogen carcinogenesis in breast cancer, N. Engl. J. Med. 354 (2006) 270-282.
20. A.J. Lee, M.X. Cai, P.E. Thomas, A.H. Conney, B.T. Zhu, Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms, Endocrinology 144 (2003) 3382-3398. (Pubitemid 36904414)
21. E. Cavalieri, D. Chakravarti, J. Guttenplan, E. Hart, J. Ingle, R. Jankowiak, P. Muti, E. Rogan, J. Russo, R. Santen, T. Sutter, Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention, Biochim. Biophys. Acta 1766 (2006) 63-78.
22. A.A. Adjei, R.M. Weinshilboum, Catecholestrogen sulfation: possible role in carcinogenesis, Biochem. Biophys. Res. Commun. 292 (2002) 402-408. (Pubitemid 34694278)
23. P.T. Mannisto, S. Kaakkola, Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors, Pharmacol. Rev. 51 (1999) 593-628.
24. B.T. Zhu, J.G. Liehr, Inhibition of catechol O-methyltransferase- catalyzed Omethylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis, J. Biol. Chem. 271 (1996) 1357-1363.
25. P. Terrier, A.J. Townsend, J.M. Coindre, T.J. Triche, K.H. Cowan, An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue, Am. J. Pathol. 137 (1990) 845-853.
26. M.A. Neves, T.C. Dinis, G. Colombo, E.M.M. Luisa Sa, Biochemical and computational insights into the anti-aromatase activity of natural catechol estrogens, J. Steroid Biochem. Mol. Biol. 110 (2008) 10-17.
27. H.F. Joosten, F.A. van Acker, D.J. van den Dobbelsteen, G.J. Horbach, E.I. Krajnc, Genotoxicity of hormonal steroids, Toxicol. Lett. 151 (2004) 113-134.
28. E. Cavalieri, E. Rogan, Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture, Ann. N.Y. Acad. Sci. 1089 (2006) 286-301.
29. Q. Zhang, R.L. Aft, M.L. Gross, Estrogen carcinogenesis: specific identification of estrogen-modified nucleobase in breast tissue from women, Chem. Res. Toxicol. 21 (2008) 1509-1513.
30. J.D. Yager, Endogenous estrogens as carcinogens through metabolic activation, J. Natl. Cancer Inst. Monogr. 27 (2000) 67-73.
31. P.S. Crooke, M.D. Ritchie, D.L. Hachey, S. Dawling, N. Roodi, F.F. Parl, Estrogens, enzymevariants, and breast cancer: a risk model, Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1620-1629. (Pubitemid 44497096)
32. T. Lanišnik Rižner, T. Šmuc, R. Rupreht, J. Šinkovec, T.M. Penning, AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer, Mol. Cell. Endocrinol. 248 (1-2) (2006) 126-135.
33. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, F. Speleman, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol. 3 (2002), RESEARCH0034.
34. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, C.T. Wittwer, The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin. Chem. 55 (2009) 611-622.
35. E.R. Simpson, Sources of estrogen and their importance, J. Steroid Biochem.Mol. Biol. 86 (2003) 225-230.
36. F. Labrie, V. Luu-The, A. Belanger, S.X. Lin, J. Simard, G. Pelletier, C. Labrie, Is dehydroepiandrosterone a hormone? J. Endocrinol. 187 (2005) 169-196.
37. J.R. Pasqualini, G.S. Chetrite, Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer, J. Steroid Biochem. Mol. Biol. 93 (2005) 221-236. (Pubitemid 40602495)
38. P.A. Foster, Steroid metabolism in breast cancer, Minerva Endocrinol. 33 (2008) 27-37.
39. V. Luu-The, Analysis and characteristics of multiple types of human 17betahydroxysteroid dehydrogenase, J. Steroid Biochem. Mol. Biol. 76 (2001) 143-151. (Pubitemid 32510676)
40. P. Vihko, P. Harkonen, P. Soronen, S. Torn, A. Herrala, R. Kurkela, A. Pulkka, O. Oduwole, V. Isomaa, 17 Beta-hydroxysteroid dehydrogenases - their role in pathophysiology, Mol. Cell. Endocrinol. 215 (2004) 83-88. (Pubitemid 38333245)
41. D. Song, G. Liu, V. Luu-The, D. Zhao, L. Wang, H. Zhang, G. Xueling, S. Li, L. Desy, F. Labrie, G. Pelletier, Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study, J. Steroid Biochem. Mol. Biol. 101 (2006) 136-144.
42. M. Plourde, A. Ferland, P. Soucy, Y. Hamdi, M. Tranchant, F. Durocher, O. Sinilnikova, V.L. The, J. Simard, Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancer, J. Steroid Biochem. Mol. Biol. 116 (2009) 134-153.
43. V. Luu-The, P. Tremblay, F. Labrie, Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women, Mol. Endocrinol. 20 (2006) 437-443.
44. S. Nagasaki, Y. Miki, J. Akahira, T. Suzuki, H. Sasano, 17Beta-hydroxysteroid dehydrogenases in human breast cancer, Ann. N.Y. Acad. Sci. 1155 (2009) 25-32.
45. G. Moeller, J. Adamski, Multifunctionality of human 17beta-hydroxysteroid dehydrogenases, Mol. Cell. Endocrinol. 248 (2006) 47-55.
46. Y. Laplante, C. Rancourt, D. Poirier, Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors, Mol. Cell. Endocrinol. 301 (2009) 146-153.
47. J. Fu, A.M.Weise, J.L. Falany, C.N. Falany, B.J. Thibodeau, F.R. Miller, T.A. Kocarek, M. Runge-Morris, Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression, Breast Cancer Res. Treat. 120 (2009) 35-45.
48. T. Šmuc, T. Lanišnik Rižner, Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines, Chem. Biol. Interact. 178 (2009) 228-233.
49. M.C. Byrns, L. Duan, S.H. Lee, I.A. Blair, T.M. Penning, Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer, J. Steroid Biochem. Mol. Biol. 118 (2010) 177-187.
50. B.P. Haynes, A.H. Straume, J. Geisler, R. A'Hern, H. Helle, I.E. Smith, P.E. Lonning, M. Dowsett, Intratumoral estrogen disposition in breast cancer, Clin. Cancer Res. 16 (2010) 1790-1801.
51. B.T. Zhu, A.J. Lee, NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms, Steroids 70 (2005) 225-244. (Pubitemid 40387377)
52. S.E. Burdall, A.M. Hanby, M.R. Lansdown, V. Speirs, Breast cancer cell lines: friend or foe? Breast Cancer Res. 5 (2003) 89-95.
53. R.M. Neve, K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F. Tong, T. Speed, P.T. Spellman, S. DeVries, A. Lapuk, N.J. Wang, W.L. Kuo, J.L. Stilwell, D. Pinkel, D.G. Albertson, F.M. Waldman, F. McCormick, R.B. Dickson, M.D. Johnson, M. Lippman, S. Ethier, A. Gazdar, J.W. Gray, A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes, Cancer Cell 10 (2006) 515-527. (Pubitemid 44854747)